GN Store Nord (OTCMKTS:GNNDY – Get Free Report) and Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership and risk.
Volatility and Risk
GN Store Nord has a beta of 1.74, suggesting that its share price is 74% more volatile than the S&P 500. Comparatively, Fresenius SE & Co. has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500.
Valuation & Earnings
This table compares GN Store Nord and Fresenius SE & Co.”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| GN Store Nord | $2.54 billion | 1.08 | $98.86 million | ($0.90) | -60.89 |
| Fresenius SE & Co. | $25.87 billion | 1.28 | $1.43 billion | $0.80 | 18.39 |
Fresenius SE & Co. has higher revenue and earnings than GN Store Nord. GN Store Nord is trading at a lower price-to-earnings ratio than Fresenius SE & Co., indicating that it is currently the more affordable of the two stocks.
Dividends
GN Store Nord pays an annual dividend of $0.45 per share and has a dividend yield of 0.8%. Fresenius SE & Co. pays an annual dividend of $0.20 per share and has a dividend yield of 1.4%. GN Store Nord pays out -50.0% of its earnings in the form of a dividend. Fresenius SE & Co. pays out 25.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Profitability
This table compares GN Store Nord and Fresenius SE & Co.’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| GN Store Nord | -2.50% | -2.01% | -0.72% |
| Fresenius SE & Co. | 6.58% | 10.24% | 4.94% |
Analyst Ratings
This is a summary of recent ratings and recommmendations for GN Store Nord and Fresenius SE & Co., as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| GN Store Nord | 0 | 3 | 2 | 0 | 2.40 |
| Fresenius SE & Co. | 0 | 0 | 3 | 0 | 3.00 |
Summary
Fresenius SE & Co. beats GN Store Nord on 11 of the 13 factors compared between the two stocks.
About GN Store Nord
GN Store Nord A/S provides hearing, audio, video, and gaming solutions in Denmark, rest of Europe, North America, and internationally. The company operates through GN Hearing and GN Audio segments. The GN Hearing segment produces and sells hearing instruments and products. The GN Audio segment supplies headsets, video cameras, and speakerphones for professional use and consumer products. It offers its products under the ReSound, Jabra, Beltone, Interton, Danavox, BlueParrott, FalCom, and SteelSeries brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.
About Fresenius SE & Co.
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Receive News & Ratings for GN Store Nord Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GN Store Nord and related companies with MarketBeat.com's FREE daily email newsletter.
